Evaluation of Capillary Blood Collection Devices (Mitra® and HemaPEN®) (MitrAlanine)

Grenoble Alpes University Hospital Center (CHU)

Status: Enrolling

Conditions: Metabolic Diseases; Phenylketonuria

Treatments: Diagnostic Test: DM-DIV MITRA®

Study type: Observational

Funder types: Other

Identifiers

NCT05894122

2023-A01180-45 (Other Identifier)

38RC22.0319

Details and patient eligibility

About

The aim is to demonstrate a new application for a blood collection device. This device is already widely used in pharmacology. It is not currently used for metabolic diseases.

Its ease of use enables repeated sampling at home. What's more, the device can be sent by post, making it ideally suited to the needs of this cohort of children, whose phenylalanine levels need to be monitored very regularly.

Enrollment: 40 estimated patients

Sex: All

Ages: 3 months to 18 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Children aged 3 months to 18 years
• suffering from phenylketonuria or hyperphenylalaninemia
• who have had a capillary and blood test including a phenylalanine assay at CHUGA
• Whose parents or legal guardians are affiliated to the social security system.
• For whom parents or legal guardians have not objected to the MitrAlanine study.

Exclusion criteria

• Parents or legal guardians opposed to the MitrAlanine study